Picture of Agile Therapeutics logo

AGRX — Agile Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Agile Therapeutics Updates Second Quarter 2022 Guidance

July 12 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS UPDATES SECOND QUARTER 2022 GUIDANCE
    * AGILE THERAPEUTICS INC -  Q2 OPERATING EXPENSES (OPEX)
EXPECTED
TO BE BELOW GUIDED RANGE
    * AGILE THERAPEUTICS - PREVIOUSLY GUIDED TWIRLA DEMAND FOR
Q2 TO
BE 20,000 TO 22,000 CYCLES AND NOW BELIEVES DEMAND WILL BE AT
MID-POINT OF THAT RANGE
    * AGILE THERAPEUTICS INC - UPDATED TWIRLA DEMAND GUIDANCE
REFLECTS
CONTINUED PROGRESS MADE IN BOTH RETAIL AND NON-RETAIL CHANNELS

Source text for Eikon:  ID:nGNXXhGmf 
Further company coverage:  AGRX.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Agile Therapeutics

See all news